China Securities Commission Approves Xinbang Asset Reorganization Plan
This article was originally published in PharmAsia News
Executive Summary
China’s Securities Regulatory Commission on March 13 approved a major asset reorganization of Xinbang in a transaction totaling RMB 130.7 million ($22.3 million).